Africa DNA Synthesis Market
Description
Africa DNA Synthesis Market, By Type (Oligonucleotide Synthesis, Gene Synthesis); By Application (Research & Development (R&D), Diagnostics, Therapeutics); By End User (Biopharmaceutical & Diagnostics Companies, Academic & Research Institutes, Contract Research Organizations (CROs)); By Country (South Africa, Egypt, Nigeria, Algeria, Kenya, Rest of Africa), Trend Analysis, Competitive Landscape & Forecast, 2019–2031Africa DNA Synthesis Market Zooming 3.2X to Cross USD 208 Million by 2031
Africa DNA Synthesis Market is booming primarily due to increasing investments in biotech research and development projects to meet a surging demand for synthetic biology and personalized medicine, adoption of CRISPR advancements, and expanding diagnostic applications across the region.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Africa DNA Synthesis Market size by value at USD 65.63 million in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Africa DNA Synthesis Market size to boom at a robust CAGR of 17.93%, reaching a value of USD 208.22 million by 2031. The significant expansion of Africa DNA Synthesis Market is driven by the increasing demand for synthetic biology in healthcare, agriculture, and environmental research and development (R&D) programs. Rising investments in genomics and biotechnology, coupled with advancements in CRISPR and gene editing technologies, are accelerating the growth of Africa DNA Synthesis Market. Expanding applications in diagnostics, personalized medicine, and vaccine development further fuel adoption. Governments’ supportive initiatives, international collaborations, and growing awareness about molecular biology tools across academic and commercial sectors also contribute to the expansion and innovations in Africa DNA Synthesis Market.
Opportunity – Adoption of Personalized Medicine and Precision Therapeutics
Africa DNA Synthesis Market is expected to record significant growth through the rising adoption of personalized medicine and precision therapeutics. Synthetic DNA enables tailored treatments based on individual genetic profiles, improving efficacy and reducing side effects. Increasing awareness, technological advancements, and regional healthcare modernization are driving demand for DNA-based diagnostics and therapies. Collaborations with global biotech firms and expanding genomic research initiatives further support this trend, positioning DNA synthesis as a cornerstone of Africa’s evolving healthcare landscape.
R&D Segment Leads Africa DNA Synthesis Market
The research and development (R&D) segment is the largest application in Africa DNA Synthesis Market. The R&D segment’s market dominance is driven by the region’s growing focus on genomics, molecular biology, and synthetic biology R&D. Academic institutions and biotech startups are increasingly utilizing synthetic DNA for experimental studies, drug discovery, and vaccine development. Government initiatives and international collaborations further support the growth of the segment, making R&D the most dominant application area. Its broad utility across scientific disciplines ensures continued investments and innovations, solidifying the R&D segment’s leadership role in the expansion of Africa DNA Synthesis Market.
Impact of Escalating Geopolitical Tensions on Africa DNA Synthesis Market
Escalating geopolitical tensions could impact the growth of Africa DNA Synthesis Market by disrupting global supply chains, delaying imports of essential reagents and equipment, and increasing operational costs. Restrictions on international trade and scientific collaboration hinder access to advanced technologies and expertise. These tensions also create uncertainties, slowing funding for biotech initiatives. As a result, research progress and innovation in DNA synthesis across Africa may face setbacks, limiting the region’s ability to compete globally in genomics and synthetic biology advancements.
Competitive Landscape
Africa DNA Synthesis Market is highly fragmented, with numerous players serving the market. Major companies dominating the market are Thermo Fisher Scientific Inc., Integrated DNA Technologies (IDT), Twist Bioscience Corporation, Eurofins Genomics, GenScript Biotech Corporation, Agilent Technologies, Inc., Bio Basic Inc., Bioneer Corporation, ATDBio Ltd., Macrogen Inc., and LGC Biosearch Technologies. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in Africa DNA Synthesis Market.
The report's in-depth analysis provides information about growth potential, upcoming trends, and Africa DNA Synthesis Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Africa DNA Synthesis Market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Africa DNA Synthesis Market is booming primarily due to increasing investments in biotech research and development projects to meet a surging demand for synthetic biology and personalized medicine, adoption of CRISPR advancements, and expanding diagnostic applications across the region.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Africa DNA Synthesis Market size by value at USD 65.63 million in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Africa DNA Synthesis Market size to boom at a robust CAGR of 17.93%, reaching a value of USD 208.22 million by 2031. The significant expansion of Africa DNA Synthesis Market is driven by the increasing demand for synthetic biology in healthcare, agriculture, and environmental research and development (R&D) programs. Rising investments in genomics and biotechnology, coupled with advancements in CRISPR and gene editing technologies, are accelerating the growth of Africa DNA Synthesis Market. Expanding applications in diagnostics, personalized medicine, and vaccine development further fuel adoption. Governments’ supportive initiatives, international collaborations, and growing awareness about molecular biology tools across academic and commercial sectors also contribute to the expansion and innovations in Africa DNA Synthesis Market.
Opportunity – Adoption of Personalized Medicine and Precision Therapeutics
Africa DNA Synthesis Market is expected to record significant growth through the rising adoption of personalized medicine and precision therapeutics. Synthetic DNA enables tailored treatments based on individual genetic profiles, improving efficacy and reducing side effects. Increasing awareness, technological advancements, and regional healthcare modernization are driving demand for DNA-based diagnostics and therapies. Collaborations with global biotech firms and expanding genomic research initiatives further support this trend, positioning DNA synthesis as a cornerstone of Africa’s evolving healthcare landscape.
R&D Segment Leads Africa DNA Synthesis Market
The research and development (R&D) segment is the largest application in Africa DNA Synthesis Market. The R&D segment’s market dominance is driven by the region’s growing focus on genomics, molecular biology, and synthetic biology R&D. Academic institutions and biotech startups are increasingly utilizing synthetic DNA for experimental studies, drug discovery, and vaccine development. Government initiatives and international collaborations further support the growth of the segment, making R&D the most dominant application area. Its broad utility across scientific disciplines ensures continued investments and innovations, solidifying the R&D segment’s leadership role in the expansion of Africa DNA Synthesis Market.
Impact of Escalating Geopolitical Tensions on Africa DNA Synthesis Market
Escalating geopolitical tensions could impact the growth of Africa DNA Synthesis Market by disrupting global supply chains, delaying imports of essential reagents and equipment, and increasing operational costs. Restrictions on international trade and scientific collaboration hinder access to advanced technologies and expertise. These tensions also create uncertainties, slowing funding for biotech initiatives. As a result, research progress and innovation in DNA synthesis across Africa may face setbacks, limiting the region’s ability to compete globally in genomics and synthetic biology advancements.
Competitive Landscape
Africa DNA Synthesis Market is highly fragmented, with numerous players serving the market. Major companies dominating the market are Thermo Fisher Scientific Inc., Integrated DNA Technologies (IDT), Twist Bioscience Corporation, Eurofins Genomics, GenScript Biotech Corporation, Agilent Technologies, Inc., Bio Basic Inc., Bioneer Corporation, ATDBio Ltd., Macrogen Inc., and LGC Biosearch Technologies. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in Africa DNA Synthesis Market.
The report's in-depth analysis provides information about growth potential, upcoming trends, and Africa DNA Synthesis Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Africa DNA Synthesis Market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Table of Contents
266 Pages
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
- 2. Executive Summary
- 3. Africa DNA Synthesis Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Increasing Demand for Synthetic DNA in Research and Diagnostics
- 3.2.1.2. Advancements in Gene Editing Technologies like CRISPR
- 3.2.1.3. Rising Investments in Biopharmaceutical and Academic Research
- 3.2.2. Restraints
- 3.2.2.1. High Cost of DNA Synthesis Equipment and Reagents
- 3.2.2.2. Limited Technical Expertise and Skilled Workforce
- 3.2.2.3. Inadequate Infrastructure for Genomic Research
- 3.2.3. Opportunities
- 3.2.3.1. Expansion of Personalized Medicine and Precision Therapeutics
- 3.2.3.2. Growth of Local Biotech Startups and Innovation Hubs
- 3.2.4. Challenges
- 3.2.4.1. Regulatory Barriers and Ethical Concerns
- 3.2.4.2. Supply Chain Disruptions and Import Dependencies
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter’s Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
- 4. Africa DNA Synthesis Market: Marketing Strategies
- 5. Africa DNA Synthesis Market: Pricing Analysis
- 6. Africa DNA Synthesis Market Overview
- 6.1. Market Size & Forecast, 2019–2031
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.1.1. Oligonucleotide Synthesis
- 6.2.1.2. Gene Synthesis
- 6.2.2. By Application
- 6.2.2.1. Research and Development
- 6.2.2.2. Diagnostics
- 6.2.2.3. Therapeutics
- 6.2.3. By End User
- 6.2.3.1. Biopharmaceutical and Diagnostics Companies
- 6.2.3.2. Academic and Research Institutes
- 6.2.3.3. Contract Research Organizations (CROs)
- 6.2.4. By Country
- 6.2.4.1. South Africa
- 6.2.4.2. Egypt
- 6.2.4.3. Kenya
- 6.2.4.4. Nigeria
- 6.2.4.5. Algeria
- 6.2.4.6. Rest of Africa
- 7. South Africa DNA Synthesis Market
- 7.1. Market Size & Forecast, 2019–2031
- 7.1.1. By Value (USD Million)
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By End User
- 8. Egypt DNA Synthesis Market
- 8.1. Market Size & Forecast, 2019–2031
- 8.1.1. By Value (USD Million)
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By End User
- 9. Kenya DNA Synthesis Market
- 9.1. Market Size & Forecast, 2019–2031
- 9.1.1. By Value (USD Million)
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By End User
- 10. Nigeria DNA Synthesis Market
- 10.1. Market Size & Forecast, 2019–2031
- 10.1.1. By Value (USD Million)
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By End User
- 11. Algeria DNA Synthesis Market
- 11.1. Market Size & Forecast, 2019–2031
- 11.1.1. By Value (USD Million)
- 11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Application
- 11.2.3. By End User
- 12. Rest of Africa DNA Synthesis Market
- 12.1. Market Size & Forecast, 2019–2031
- 12.1.1. By Value (USD Million)
- 12.2. Market Share & Forecast
- 12.2.1. By Type
- 12.2.2. By Application
- 12.2.3. By End User
- 13. Competitive Landscape
- 13.1. List of Key Players and Their Offerings
- 13.2. Africa DNA Synthesis Market Company Market Share Analysis, 2024
- 13.3. Competitive Benchmarking, By Operating Parameters
- 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
- 14. Impact of Escalating Geopolitical Tensions on Africa DNA Synthesis Market
- 15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- 15.1. Thermo Fisher Scientific Inc.
- 15.2. Integrated DNA Technologies (IDT)
- 15.3. Twist Bioscience Corporation
- 15.4. Eurofins Genomics
- 15.5. GenScript Biotech Corporation
- 15.6. Agilent Technologies, Inc.
- 15.7. Bio Basic Inc.
- 15.8. Bioneer Corporation
- 15.9. ATDBio Ltd
- 15.10. Macrogen Inc.
- 15.11. LGC Biosearch Technologies
- 15.12. Other Prominent Players
- 16. Key Strategic Recommendations
- 17. Research Methodology
- 17.1. Qualitative Research
- 17.1.1. Primary & Secondary Research
- 17.2. Quantitative Research
- 17.3. Market Breakdown & Data Triangulation
- 17.3.1. Secondary Research
- 17.3.2. Primary Research
- 17.4. Breakdown of Primary Research Respondents, By Region
- 17.5. Assumptions & Limitations
- *Financial information of non-listed companies can be provided as per availability.
- **The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
- List of Figures
- Figure 1 Africa DNA Synthesis Segmentation
- Figure 2 Africa DNA Synthesis Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2024
- Figure 4 Africa DNA Synthesis Market Size, By Value (USD Million), 2019–2031
- Figure 5 Africa DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Figure 6 Africa DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Figure 7 Africa DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Figure 8 Africa DNA Synthesis Market Share, By Country, By Value, 2019–2031
- Figure 9 South Africa DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Figure 10 South Africa DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Figure 11 South Africa DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Figure 12 Egypt DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Figure 13 Egypt DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Figure 14 Egypt DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Figure 15 Kenya DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Figure 16 Kenya DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Figure 17 Kenya DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Figure 18 Nigeria DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Figure 19 Nigeria DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Figure 21 Nigeria DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Figure 22 Algeria DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Figure 23 Algeria DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Figure 24 Algeria DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Figure 25 Rest of Africa DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Figure 26 Rest of Africa DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Figure 27 Rest of Africa DNA Synthesis Market Share, By End User, By Value, 2019–2031
- List of Tables
- Table 1 Africa DNA Synthesis Market Size, By Value (USD Million), 2019–2031
- Table 2 Africa DNA Synthesis Market Size, By Type, By Value, 2019–2031
- Table 3 Africa DNA Synthesis Market Size, By Application, By Value, 2019–2031
- Table 4 Africa DNA Synthesis Market Size, By End User, By Value, 2019–2031
- Table 5 Africa DNA Synthesis Market Size, By Size, By Value, 2019–2031
- Table 6 Africa DNA Synthesis Market Share, By Country, By Value, 2019–2031
- Table 7 South Africa DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Table 8 South Africa DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Table 9 South Africa DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Table 10 Egypt DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Table 11 Egypt DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Table 12 Egypt DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Table 13 Kenya DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Table 14 Kenya DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Table 15 Kenya DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Table 16 Nigeria DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Table 17 Nigeria DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Table 18 Nigeria DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Table 19 Algeria DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Table 20 Algeria DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Table 21 Algeria DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Table 22 Rest of Africa DNA Synthesis Market Share, By Type, By Value, 2019–2031
- Table 23 Rest of Africa DNA Synthesis Market Share, By Application, By Value, 2019–2031
- Table 24 Rest of Africa DNA Synthesis Market Share, By End User, By Value, 2019–2031
- Table 25 Thermo Fisher Scientific Inc. Company Overview
- Table 26 Thermo Fisher Scientific Inc. Financial Overview
- Table 27 Integrated DNA Technologies (IDT) Company Overview
- Table 28 Integrated DNA Technologies (IDT) Financial Overview
- Table 29 Twist Bioscience Corporation Company Overview
- Table 30 Twist Bioscience Corporation Financial Overview
- Table 31 Eurofins Genomics Company Overview
- Table 32 Eurofins Genomics Financial Overview
- Table 33 GenScript Biotech Corporation Company Overview
- Table 34 GenScript Biotech Corporation Financial Overview
- Table 35 Agilent Technologies, Inc. Company Overview
- Table 36 Agilent Technologies, Inc. Financial Overview
- Table 37 Bio Basic Inc. Company Overview
- Table 38 Bio Basic Inc. Financial Overview
- Table 39 Bioneer Corporation Company Overview
- Table 40 Bioneer Corporation Financial Overview
- Table 41 ATDBio Ltd Company Overview
- Table 42 ATDBio Ltd Financial Overview
- Table 43 Macrogen Inc. Company Overview
- Table 44 Macrogen Inc. Financial Overview
- Table 45 LGC Biosearch Technologies Company Overview
- Table 46 LGC Biosearch Technologies Financial Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



